To explore the effect of each AKT isoform in ovarian cancer, we analyzed the correlation between in vivo AKT1/AKT2/AKT3 levels and patients' probability of progression-free survival, based on data from a clinical study of patients suffering from ovarian cancer (http://kmplot.com/analysis/index.php?p=service&cancer=ovar). This evidence concerns the gene AKT1 and ovarian cancer.